NCT06562647 2026-02-13SY001 Targets Mesothelin in a Single-arm, Dose-increasing Setting in Subjects With Advanced Solid TumorsCell Origin Biotech (Hangzhou) Co., Ltd.Phase NA Recruiting2 enrolled
NCT03458221 2023-04-18STAPOVERGynaecologisch Oncologisch Centrum ZuidPhase 2/3 Recruiting148 enrolled